HM
HealthCor Management Portfolio holdings
AUM
$109M
This Quarter Return
+6.17%
1 Year Return
+11.46%
3 Year Return
+50.01%
5 Year Return
+144.68%
10 Year Return
–
AUM
$1.58B
AUM Growth
+$1.58B
(-5.3%)
Cap. Flow
-$124M
Cap. Flow
% of AUM
-7.82%
Top 10 Holdings %
Top 10 Hldgs %
52.19%
Holding
66
New
19
Increased
10
Reduced
15
Closed
15
Top Buys
| 1 |
Gilead Sciences
GILD
|
$118M |
| 2 |
Pfizer
PFE
|
$100M |
| 3 |
Bausch Health
BHC
|
$93M |
| 4 |
Keysight
KEYS
|
$69M |
| 5 |
Illumina
ILMN
|
$64.6M |
Top Sells
| 1 |
MDRX
Veradigm Inc. Common Stock
MDRX
|
$96.7M |
| 2 |
WMGI
Wright Medical Group Inc
WMGI
|
$95.4M |
| 3 |
Intuitive Surgical
ISRG
|
$73.2M |
| 4 |
CBST
CUBIST PHARMACEUTICALS INC
CBST
|
$73M |
| 5 |
Danaher
DHR
|
$72.6M |
Sector Composition
| 1 | Healthcare | 81.66% |
| 2 | Technology | 4.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
MNK
1
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $131M | 7.31% | 1,325,000 -475,000 | -26% | -$47M |
|
|
2
Gilead Sciences
GILD
$140B
| $118M | 6.57% | +1,250,000 | New | +$118M |
|
|
3
Pfizer
PFE
$141B
| $100M | 5.59% | +3,219,100 | New | +$100M |
|
|
4
Bausch Health
BHC
$2.74B
| $93M | 5.19% | +650,000 | New | +$93M |
|
|
HZNP
5
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $72.2M | 4.02% | 5,600,000 +2,025,000 | +57% | +$26.1M |
|
|
6
Keysight
KEYS
$28.1B
| $69M | 3.85% | +2,043,826 | New | +$69M |
|
|
7
Illumina
ILMN
$15.8B
| $64.6M | 3.6% | +350,000 | New | +$64.6M |
|
|
SLXP
8
DELISTED
SALIX PHARMACEUTICALS LTD DEL
SLXP
| $60.3M | 3.36% | 525,000 -410,100 | -44% | -$47.1M |
|
9
Labcorp
LH
$23.1B
| $59.3M | 3.31% | +550,000 | New | +$59.3M |
|
|
MDVN
10
DELISTED
MEDIVATION, INC.
MDVN
| $57.3M | 3.19% | 575,000 +50,000 | +10% | +$4.98M |
|
11
Thermo Fisher Scientific
TMO
$186B
| $50.1M | 2.79% | 400,000 +344,700 | +623% | +$43.2M |
|
12
Universal Health Services
UHS
$11.6B
| $50.1M | 2.79% | 450,000 -50,000 | -10% | -$5.56M |
|
|
OCR
13
DELISTED
OMNICARE INC
OCR
| $49.2M | 2.74% | 675,000 +325,000 | +93% | +$23.7M |
|
|
WBMD
14
DELISTED
WebMD Health Corp.
WBMD
| $48.4M | 2.7% | 1,225,000 -56,200 | -4% | -$2.22M |
|
15
Boston Scientific
BSX
$156B
| $45.9M | 2.56% | +3,461,200 | New | +$45.9M |
|
16
Avanos Medical
AVNS
$554M
| $43.2M | 2.41% | +950,800 | New | +$43.2M |
|
|
17
Intuitive Surgical
ISRG
$170B
| $40.5M | 2.26% | 76,600 -138,400 | -64% | -$73.2M |
|
18
Viatris
VTRS
$12.3B
| $39.4M | 2.2% | 698,800 -851,200 | -55% | -$48M |
|
|
TSRO
19
DELISTED
TESARO, Inc.
TSRO
| $39.1M | 2.18% | 1,050,000 -148,795 | -12% | -$5.53M |
|
20
McKesson
MCK
$85.4B
| $36.5M | 2.03% | 175,600 -99,400 | -36% | -$20.6M |
|
|
NUVA
21
DELISTED
NuVasive, Inc.
NUVA
| $35.4M | 1.97% | 750,000 -450,000 | -38% | -$21.2M |
|
22
Cardinal Health
CAH
$35.5B
| $31.1M | 1.73% | +385,200 | New | +$31.1M |
|
23
Zimmer Biomet
ZBH
$21B
| $30M | 1.67% | +264,400 | New | +$30M |
|
|
AMRI
24
DELISTED
Albany Molecular Research Inc
AMRI
| $26M | 1.45% | 1,600,000 +200,000 | +14% | +$3.26M |
|
|
ALXN
25
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $23.5M | 1.31% | 127,100 -22,900 | -15% | -$4.24M |
|